In 2020, 2.3 million women were diagnosed with breast cancer and 685000 breast cancer deaths had occurred globally (World Health Organization). Thankfully, the cancer research does not stop – recently, researchers have developed a novel targeted therapy for triple-negative breast cancer that uses a revolutionary nano-carrier to deliver gambogic acid boosting the effectiveness of existing treatments.
